Bleeding | HBTa (n = 14) | Continuous use of warfarin (n = 10) | One-day skip of DOAC (n = 27) | Control (n = 643) |
---|---|---|---|---|
n | 3 | 1 | 4 | 20 |
Per-patient, % | 21.4* | 10.0 | 14.8* | 3.1 |
Per polyp, % | 9.7* | 6.3 | 6.5* | 1.5 |
Odds | 4.94 | 3.29 | 4.94 | 1 |
(95%CI) | (1.04–23.5) | (0.40–27.2) | (1.57–15.5) |  |
p | 0.045 | 0.27 | 0.0062 | Â |